Given the widespread expression of CLEC14A in human solid tumors and the non-MHC restricted nature of CAR-expressing T cells, CLEC14A-specific CAR T cells could potentially treat a wide range of cancer patients. The gene discussed is CLEC14A; the disease is cancer.